Orforglipron hemicalcium hydrate | MedChemExpress (MCE)
Orforglipron hemicalcium hydrate (LY3502970 hemicalcium hydrate; GLP-1 receptor agonist 1 hemicalcium hydrate) is the calcium salt hydrate form of Orforglipron (HY-112185). Orforglipron is an orally active agonist for Glucagon-like peptide-1 receptor (GLP-1R), which exhibits potency in ameliorating the type 2 diabete[1].
| Trivial name | Orforglipron hemicalcium hydrate |
| Catalog Number | HY-112185A |
| Alternative Name(s) | LY3502970 hemicalcium hydrate; GLP-1 receptor agonist 1 hemicalcium hydrate |
| Research Area | Metabolic Disease |
| CAS# | 3008544-96-2 |
| Purity | ≥98.0% |
| SMILES | C[C@@H]1[C@](N2C3=CC=C([C@]4([H])CC(C)(OCC4)C)C=C3C=C2C(N5[C@H](C6=C(N7C(N(C8=CC=C(N(N=C9)C)C9=C8F)C=C7)=O)N(C%10=CC(C)=C(C(C)=C%10)F)N=C6CC5)C)=O)(C(N%11)=NOC%11=O)C1.[0.5].[Ca].O |
| Size | 5 mg |
| Supplier Page | https://www.medchemexpress.com/orforglipron-hemicalcium-hydrate.html |